A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.

Author: BytzerP, ChangL, CorinaldesiR, Dunger-BaldaufC, Müller-LissnerS, RueeggP, SchnekenbuehlS, TackJ, ViegasA

Paper Details 
Original Abstract of the Article :
BACKGROUND: It has been proposed that treatments for irritable bowel syndrome with constipation (IBS-C) should provide rapid symptomatic relief, be intermittent, and effective upon repeated use. AIMS: To evaluate the efficacy and safety of tegaserod on IBS symptoms, and its impact on quality of lif...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774790/

データ提供:米国国立医学図書館(NLM)

Tegaserod for Irritable Bowel Syndrome with Constipation: A Camel's Guide to Relief

Irritable bowel syndrome with constipation (IBS-C) is a common gastrointestinal disorder that can have a significant impact on a person's quality of life. It's like a camel's journey being interrupted by a sandstorm, making it difficult to reach its destination. This study explores the effectiveness of tegaserod, a medication used to treat IBS-C, in providing rapid and sustained relief from symptoms.

The researchers conducted a randomized controlled trial involving women with IBS-C. This is akin to testing different camel saddles to see which one provides the most comfortable ride. The study found that tegaserod was significantly more effective than placebo in reducing IBS-C symptoms, both in the initial treatment period and upon repeated use. This means that the drug not only provides immediate relief but also has a lasting impact on the condition. It's like finding a clear path through the desert, one that allows the camel to continue its journey without interruption.

Tegaserod: A Promising Option for IBS-C

This research provides strong evidence for the efficacy of tegaserod in treating IBS-C. The drug demonstrated a clear advantage over placebo in improving symptoms and quality of life for patients. It's like finding a hidden oasis that provides a respite from the harsh conditions of the desert.

The Impact on Everyday Life and Future Directions

The findings suggest that tegaserod can be a valuable tool for managing IBS-C, allowing individuals to lead more fulfilling lives. This research highlights the importance of finding solutions for these common gastrointestinal disorders. It's like discovering a new route through the desert, one that makes travel more efficient and enjoyable.

Dr. Camel's Conclusion

This study shows that tegaserod is a promising treatment option for IBS-C, providing a much-needed respite for those who struggle with this condition. It's like finding a refreshing oasis in the heart of the desert, offering a sense of relief and rejuvenation.

Date :
  1. Date Completed 2005-12-12
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

16020489

DOI: Digital Object Identifier

PMC1774790

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.